cholestyramine resin has been researched along with colforsin in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 13,460 | 46 | 1,298 |
| Protein | Taxonomy | cholestyramine resin (IC50) | colforsin (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
| Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Betteridge, DJ; Cooper, MB; Gasser, JA; Saggerson, ED; Tan, KC | 1 |
1 other study(ies) available for cholestyramine resin and colforsin
| Article | Year |
|---|---|
Decreased sensitivity to adenosine in platelets from patients with familial hypercholesterolaemia--a change reversed by cholestyramine treatment.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adult; Cholestyramine Resin; Colforsin; Cyclic AMP; Epoprostenol; Female; Humans; Hyperlipoproteinemia Type II; Male; Platelet Aggregation Inhibitors | 1993 |